Correlation Between Milestone Pharmaceuticals and Phio Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Phio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Phio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Phio Pharmaceuticals Corp, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Phio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Phio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Phio Pharmaceuticals.
Diversification Opportunities for Milestone Pharmaceuticals and Phio Pharmaceuticals
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Milestone and Phio is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Phio Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phio Pharmaceuticals Corp and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Phio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phio Pharmaceuticals Corp has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Phio Pharmaceuticals go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Phio Pharmaceuticals
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.55 times more return on investment than Phio Pharmaceuticals. However, Milestone Pharmaceuticals is 1.81 times less risky than Phio Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Phio Pharmaceuticals Corp is currently generating about -0.03 per unit of risk. If you would invest 406.00 in Milestone Pharmaceuticals on August 30, 2024 and sell it today you would lose (219.00) from holding Milestone Pharmaceuticals or give up 53.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Phio Pharmaceuticals Corp
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Phio Pharmaceuticals Corp |
Milestone Pharmaceuticals and Phio Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Phio Pharmaceuticals
The main advantage of trading using opposite Milestone Pharmaceuticals and Phio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Phio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will offset losses from the drop in Phio Pharmaceuticals' long position.The idea behind Milestone Pharmaceuticals and Phio Pharmaceuticals Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Phio Pharmaceuticals vs. Bright Minds Biosciences | Phio Pharmaceuticals vs. HP Inc | Phio Pharmaceuticals vs. Intel | Phio Pharmaceuticals vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |